BRIGNOLA, CORRADO
 Distribuzione geografica
Continente #
NA - Nord America 832
EU - Europa 545
AS - Asia 279
AF - Africa 41
OC - Oceania 2
Totale 1.699
Nazione #
US - Stati Uniti d'America 828
SE - Svezia 200
SG - Singapore 168
DE - Germania 94
IE - Irlanda 79
CN - Cina 56
GB - Regno Unito 49
IT - Italia 45
BG - Bulgaria 35
CI - Costa d'Avorio 21
JO - Giordania 21
TG - Togo 18
CH - Svizzera 17
IN - India 16
IR - Iran 13
FI - Finlandia 9
FR - Francia 9
CA - Canada 4
JP - Giappone 3
RU - Federazione Russa 3
AU - Australia 2
RO - Romania 2
BE - Belgio 1
ES - Italia 1
HK - Hong Kong 1
LT - Lituania 1
NG - Nigeria 1
TW - Taiwan 1
ZA - Sudafrica 1
Totale 1.699
Città #
Chandler 182
Singapore 146
Santa Clara 108
Dublin 79
Princeton 72
Ashburn 71
Southend 46
Boardman 39
Berlin 35
Sofia 31
Abidjan 21
Amman 21
Lomé 18
Bern 17
Fairfield 10
Milan 10
Guangzhou 8
Helsinki 8
Washington 8
Frankfurt am Main 6
Houston 6
Olalla 6
San Diego 6
Woodbridge 6
Bologna 5
Los Angeles 5
New York 5
Nuremberg 5
Perugia 5
Turin 5
Wuhan 5
Chicago 4
Falkenstein 4
Cambridge 3
Paris 3
Shanghai 3
Suzhou 3
Zanjan 3
Andover 2
Augusta 2
Beijing 2
Bühl 2
Chongqing 2
Dongying 2
Hamburg 2
Leawood 2
Montreal 2
Piacenza 2
Prato 2
Prescot 2
Redmond 2
Sacramento 2
Seattle 2
Albuquerque 1
Ann Arbor 1
Baia Mare 1
Boydton 1
Bremen 1
Brussels 1
Buffalo 1
Büdelsdorf 1
Cedar Knolls 1
Chengdu 1
Council Bluffs 1
Fort Worth 1
Foshan 1
Harbin 1
Henderson 1
Jinan 1
Kunming 1
Lagos 1
Lappeenranta 1
Lianyun 1
Ma'anshan 1
Naples 1
Napoli 1
Ningbo 1
Phoenix 1
Pisa 1
Pune 1
Raleigh 1
San Lazzaro di Savena 1
Sebokeng 1
Shenzhen 1
Springfield 1
Suffern 1
Taiyuan 1
Tianjin 1
Toronto 1
Torre Del Greco 1
Weifang 1
Wilmington 1
Winnipeg 1
Yuncheng 1
Yunfu 1
Zhengzhou 1
Totale 1.091
Nome #
5-Aminosalicylic acid in patients with ulcerative colitis in remission: plasma levels after administration of a new rectal enema 97
5-Aminosalicylic acid suppositories in the management of ulcerative colitis 85
5-Aminosalicylic acid as enemas or suppositories in distal ulcerative colitis? 68
[Abdominal scintigraphy with leukocytes marked with indium-111 in Crohn disease: clinical importance and prognostic usefulness] 66
Analysis of biological variables in Crohn's disease [4] 62
A Possible mechanism of action of sulfasalazine and 5-aminosalicylic acid in inflammatory bowel diseases: Interaction with oxygen free radicals 61
Topical administration of 5-aminosalicylic acid enemas in patients with ulcerative colitis. Studies on rectal absorption and excretion 60
5-Aminosalicylic acid for the treatment of inflammatory bowel diseases 59
Bioavailability of single and multiple doses of a new oral formulation of 5‐ASA in patients with inflammatory bowel disease and healthy volunteers 58
Changes in splanchnic hemodynamics in inflammatory bowel disease non-invasive assessment by doppler ultrasound flowmetry 52
Efficacy of 5-aminosalicylic acid enemas versus hydrocortisone enemas in ulcerative colitis 52
Long-term efficacy of bismuth carbomer enemas in patients with treatment-resistant chronic pouchitis 51
Effects of new fish oil derivative on fatty acid phospholipid-membrane pattern in a group of Crohn's disease patients 50
Influence of steroid treatment's duration in patients with active Crohn's disease 50
Respiratory burst of circulating polymorphonuclear leukocytes and plasma elastase levels in patients with inflammatory bowel disease in remission 47
Macrophage subpopulations in pouchitis 47
Bronchopulmonary involvement in ulcerative colitis 47
Scavenger effect of sulphasalazine (SASP), 5-aminosalicylic acid (5-ASA), and olsalazine (OAZ) (I) 45
Role of rectal formulations: Enemas 44
Scavenger effect of sulfasalazine, 5-aminosalicylic acid, and olsalazine on superoxide radical generation 43
Retrograde spread of 5-aminosalicylic acid enemas in patients with active ulcerative colitis 42
Interleukin 1 beta (IL-1 beta) release from fresh and cultured colonic mucosa in patients with ulcerative colitis (UC) 42
Lack of effect of antineutrophil cytoplasmic antibodies associated with ulcerative colitis on superoxide anion production from neutrophils 42
Placebo-controlled trial of oral 5-ASA in relapse prevention of Crohn's disease 41
Optimum dosage of 5-Aminosalicylic acid as rectal enemas in patients with active ulcerative colitis 41
Topical treatment with 5-aminosalicylic in distal ulcerative colitis by using a new suppository preparation - A double-blind placebo controlled trial 41
Requirements for the use of intestinal action antibiotics in the treatment of ulcerative colitis 41
Interleukin 1 in ulcerative colitis 40
Comparison of oral with rectal mesalazine in the treatment of ulcerative proctitis 40
Enhanced mucosal interleukin-6 and -8 in Helicobacter pylori-positive dyspeptic patients 39
Comparison of mesalazine suppositories in proctitis and distal proctosigmoiditis 37
Short report: zinc sulphate supplementation corrects abnormal erythrocyte membrane long‐chain fatty acid composition in patients with Crohn's disease 35
Pentasa in maintenance treatment of ulcerative colitis 32
Mucosal concentrations of interleukin-1β, interleukin-6, interleukin-8, and tumor necrosis factor-α in pelvic ileal pouches 31
Spread and distribution of 5-ASA colonic foam and 5-ASA enema in patients with ulcerative colitis 29
Systemic availability of 5-aminosalicylic acid: Comparison of delayed release and an azo-bond preparation 29
Factors affecting recurrence in Crohn's disease: Results of a prospective audit 12
Totale 1.758
Categoria #
all - tutte 8.576
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.576


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022386 0 0 0 0 0 0 0 0 133 52 153 48
2022/2023752 72 114 69 48 45 59 21 59 146 22 34 63
2023/2024185 13 33 17 16 18 49 3 11 4 16 5 0
2024/2025435 49 79 60 52 155 40 0 0 0 0 0 0
Totale 1.758